Prevalence and severity of pruritus in cutaneous T cell lymphoma

International Journal of Dermatology

Volumn 51, Issue 8, 2012, Pages 930-934

  Vij, Alok ^a   Duvic, Madeleine ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b University of Texas Health Science Center at Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARAB; ARTICLE; ASIAN; CANCER STAGING; CAUCASIAN; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; DISEASE SEVERITY; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYCOSIS FUNGOIDES; PRESCHOOL CHILD; PREVALENCE; PRURITUS; RACE DIFFERENCE; RETROSPECTIVE STUDY; SCHOOL CHILD; SELF REPORT; SEZARY SYNDROME; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; PREVALENCE; PRURITUS; RETROSPECTIVE STUDIES; SELF REPORT; SEVERITY OF ILLNESS INDEX; SEZARY SYNDROME; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84864016020     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.05188.x     Document Type: Article

References (27)

1. Burg G, Kempf W, Cozzio A, et al. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol 2005; 32: 647-674.
2. Bradford PT, Devesa SS, Anderson WF, Toro JR. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood 2009; 113: 5064-5073.
3. Criscione VD, Weinstock MA. Incidence of cutaneous T cell lymphoma in the United States, 1973-2002. Arch Dermatol 2007; 143: 854-859.
4. Humme D, Lukowsky A, Sterry W. Diagnostic tools in mycosis fungoides. G Ital Dermatol Venereol 2010; 145: 375-384.
5. Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110: 1713-1722.
6. Campbell JJ, Clark RA, Watanabe R, Kupper TS. Sézary syndrome and MF arise from distinct T cell subsets: a biologic rationale for their distinct clinical behaviors. Blood 2010; 116: 767-771.
7. Vidulich KA, Talpur R, Bassett RL, Duvic M. Overall survival in erythrodermic cutaneous T cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T cell lymphoma. Int J Dermatol 2009; 48: 243-252.
8. Lansigan F. Navigating the treatment choices for mycosis fungoides. Oncology (Williston Park) 2010; 24: 508.
9. Green SB, Byar DP, Lamberg SI. Prognostic variables in mycosis fungoides. Cancer 1981; 47: 2671-2677.
10. Grob JJ, Revuz J, Ortonne JP, et al. Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol 2005; 152: 289-295.
11. Grob JJ. Why are quality of life instruments not recognized as reference measures in therapeutic trials of chronic skin disorders? J Invest Dermatol 2007; 127: 2299-2301.
12. Cleeland CS, Mendoza RT, Wang XS, et al. Assessing symptom distress in cancer patients: the MD Anderson Symptom Inventory. Cancer 2000; 89: 1634-1646.
13. Chren MM, Lasek RJ, Quinn LM, et al. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996; 107: 707-713.
14. Demierre MF, Gan S, Jones J, Miller DR. Significant impact of cutaneous T cell lymphoma on patients' quality of life: results of a 2005 National Cutaneous Lymphoma Foundation Survey. Cancer 2006; 107: 2504-2511.
15. Lansigan F, Foss FM. Current and emerging treatment strategies for cutaneous T cell lymphoma. Drugs 2010; 70: 273-286.
16. Trancrede-Bohin E, Ionescu MA, de la Salmoniere P, et al. Prognostic value of blood eosinophilia in primary cutaneous T cell lymphoma. Arch Dermatol 2004; 140: 1057-1061.
17. Papadavid E, Economidou J, Psarra A, et al. The relevance of peripheral blood T helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome. Br J Dermatol 2003; 148: 709-718.
18. Talpur R, Bassett R, Duvic M. Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sézary syndrome. Br J Dermatol 2008; 159: 105-112.
19. Grob JJ, Auquier P, Martin S, et al. Development and validation of a quality of life measurement for chronic skin disorders in French: VQ-Dermato. The Réseaud Epidémiologie en Dermatologie. Dermatology 1999; 199: 213-222.
20. Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet 2003; 361: 690-694.
21. Demierre MF, Tien A, Miller D. Health-related quality-of-life assessment in patients with cutaneous T cell lymphoma. Arch Dermatol 2005; 141: 325-330.
22. Townsend A, Wyke S, Hunt K. Self-managing and managing self: practical and moral dilemmas in accounts of living with chronic illness. Chronic Illn 2006; 2: 185-194.
23. Evers AW, Lu Y, Duller P, et al. Common burden of chronic skin diseases? Contributors to psychological distress in adults with psoriasis and atopic dermatitis. Br J Dermatol 2005; 152: 1275-1281.
24. Fortune DG, Richards HL, Kirby B, et al. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol 2003; 139: 752-756.
25. Fortune DG, Richards HL, Kirby B, et al. A cognitive-behavioral symptom management program as an adjunct in psoriasis therapy. Br J Dermatol 2002; 146: 458-465.
26. Phan NQ, Bernhard JD, Luger TA, Stander S. Antipruritic treatment with systemic mu-opioid receptor antagonists: a review. J Am Acad Dermatol 2010; 63: 680-688.
27. Schmelz M, Schmidt R, Bickel A, et al. Specific C-receptors for itch in human skin. J Neurosci 1997; 17: 8003-8008.